BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27038679)

  • 1. Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation.
    Sorkin T; Strautnieks S; Foskett P; Peddu P; Thompson RJ; Heaton N; Quaglia A
    Hum Pathol; 2016 Jul; 53():153-8. PubMed ID: 27038679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
    Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
    Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before.
    Sempoux C; Bisig B; Couchy G; Balabaud C; Zucman-Rossi J; Bioulac-Sage P
    Hum Pathol; 2017 Apr; 62():122-125. PubMed ID: 27984126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
    Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
    Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
    Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
    Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
    Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
    Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
    Kakar S; Grenert JP; Paradis V; Pote N; Jakate S; Ferrell LD
    Mod Pathol; 2014 Nov; 27(11):1499-1509. PubMed ID: 24743216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia.
    Closset J; Veys I; Peny MO; Braude P; Van Gansbeke D; Lambilliotte JP; Gelin M
    Hepatogastroenterology; 2000; 47(35):1382-4. PubMed ID: 11100357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.
    Roncalli M; Sciarra A; Tommaso LD
    Clin Mol Hepatol; 2016 Jun; 22(2):199-211. PubMed ID: 27189732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
    Saldarriaga J; Bisig B; Couchy G; Castain C; Zucman-Rossi J; Balabaud C; Sempoux C; Bioulac-Sage P
    Histopathology; 2017 Dec; 71(6):989-993. PubMed ID: 28618047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
    Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
    Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular Carcinoma Arising in an HNF-1α-Mutated Adenoma in a 23-Year-Old Woman with Maturity-Onset Diabetes of the Young: A Case Report.
    Stueck AE; Qu Z; Huang MA; Campreciós G; Ferrell LD; Thung SN
    Semin Liver Dis; 2015 Nov; 35(4):444-9. PubMed ID: 26676820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas.
    Sempoux C; Gouw ASH; Dunet V; Paradis V; Balabaud C; Bioulac-Sage P
    Am J Surg Pathol; 2021 Apr; 45(4):477-487. PubMed ID: 33560657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical pitfalls in the diagnosis of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
    Bioulac-Sage P; Sempoux C; Balabaud C
    Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):245-9. PubMed ID: 24525010
    [No Abstract]   [Full Text] [Related]  

  • 17. Pigmented well-differentiated hepatocellular neoplasm with beta-catenin mutation.
    Souza LN; de Martino RB; Thompson R; Strautnieks S; Heaton ND; Quaglia A
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):660-4. PubMed ID: 26663015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.
    Chen YW; Jeng YM; Yeh SH; Chen PJ
    Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
    Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
    Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype phenotype classification of hepatocellular adenoma.
    Bioulac-Sage P; Blanc JF; Rebouissou S; Balabaud C; Zucman-Rossi J
    World J Gastroenterol; 2007 May; 13(19):2649-54. PubMed ID: 17569132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.